OMERS ADMINISTRATION Corp Reduces Position in Waters Corporation $WAT

OMERS ADMINISTRATION Corp trimmed its holdings in Waters Corporation (NYSE:WAT) by 52.0% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,113 shares of the medical instruments supplier’s stock after selling 5,539 shares during the period. OMERS ADMINISTRATION Corp’s holdings in Waters were worth $1,918,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Pinnacle Associates Ltd. boosted its position in Waters by 0.3% during the fourth quarter. Pinnacle Associates Ltd. now owns 7,608 shares of the medical instruments supplier’s stock worth $2,890,000 after acquiring an additional 26 shares during the last quarter. Exencial Wealth Advisors LLC lifted its stake in Waters by 1.7% in the 4th quarter. Exencial Wealth Advisors LLC now owns 1,681 shares of the medical instruments supplier’s stock worth $638,000 after purchasing an additional 28 shares in the last quarter. Clearstead Advisors LLC lifted its stake in Waters by 5.1% in the 4th quarter. Clearstead Advisors LLC now owns 616 shares of the medical instruments supplier’s stock worth $234,000 after purchasing an additional 30 shares in the last quarter. Avalon Trust Co boosted its holdings in shares of Waters by 2.3% during the 1st quarter. Avalon Trust Co now owns 1,330 shares of the medical instruments supplier’s stock worth $396,000 after purchasing an additional 30 shares during the last quarter. Finally, Integrated Wealth Concepts LLC boosted its holdings in shares of Waters by 2.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after purchasing an additional 30 shares during the last quarter. 94.01% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Waters

In other news, Director Christopher A. Kuebler sold 3,626 shares of the stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the completion of the transaction, the director directly owned 17,808 shares in the company, valued at approximately $7,086,515.52. This represents a 16.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.31% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on WAT shares. TD Cowen raised Waters from a “hold” rating to a “buy” rating and increased their price target for the company from $408.00 to $475.00 in a report on Wednesday, August 5th. Wells Fargo & Company boosted their price objective on Waters from $370.00 to $400.00 and gave the stock an “equal weight” rating in a research note on Wednesday, August 5th. Wolfe Research started coverage on Waters in a report on Tuesday, June 2nd. They issued an “outperform” rating and a $425.00 target price for the company. Evercore reaffirmed an “outperform” rating and issued a $420.00 target price on shares of Waters in a research note on Wednesday, August 5th. Finally, Citigroup lifted their price target on Waters from $425.00 to $470.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Three investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $420.35.

Waters Stock Up 0.2%

WAT stock opened at $415.07 on Thursday. The firm has a market cap of $40.78 billion, a PE ratio of 103.51, a PEG ratio of 2.41 and a beta of 1.19. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.29 and a current ratio of 1.86. The firm’s 50 day moving average price is $385.08 and its 200-day moving average price is $347.72. Waters Corporation has a one year low of $282.77 and a one year high of $421.74.

Waters (NYSE:WAT) last issued its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share for the quarter, topping the consensus estimate of $3.01 by $0.04. The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.62 billion. Waters had a return on equity of 11.27% and a net margin of 3.58%.The firm’s revenue for the quarter was up 113.3% compared to the same quarter last year. During the same period in the prior year, the business posted $2.95 earnings per share. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. On average, equities research analysts anticipate that Waters Corporation will post 14.56 EPS for the current year.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.